Trial Profile
Scientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in Children
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Jul 2023
Price :
$35
*
At a glance
- Drugs Dupilumab (Primary) ; Secukinumab (Primary) ; Ustekinumab (Primary)
- Indications Congenital ichthyosiform erythroderma
- Focus Therapeutic Use
- 13 Aug 2021 New trial record